PHARMAC and long-acting insulin analogues: A poor man's insulin pump - But not available to the poor man

New Zealand Medical Journal

Volumn 118, Issue 1221, 2005, Pages

  Krebs, Jeremy ^a  

^a WELLINGTON HOSPITAL   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; INSULIN; INSULIN DERIVATIVE; INSULIN GLARGINE; ISOPHANE INSULIN; LONG ACTING DRUG; DRUG DERIVATIVE; GLARGINE;

ARTICLE; DRUG COST; FINANCIAL MANAGEMENT; GLUCOSE BLOOD LEVEL; GLUCOSE HOMEOSTASIS; HEALTH CARE ACCESS; HUMAN; HYPOGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN PUMP; INSULIN TREATMENT; NEW ZEALAND; NON INSULIN DEPENDENT DIABETES MELLITUS; PRESCRIPTION; DIABETES MELLITUS; DRUG INDUSTRY; ECONOMICS; HEALTH INSURANCE;

DIABETES MELLITUS; DRUG COSTS; DRUG INDUSTRY; FINANCING, GOVERNMENT; HUMANS; INSULIN; INSURANCE, PHARMACEUTICAL SERVICES; NEW ZEALAND;

EID: 27244439496     PISSN: 11758716     EISSN: 11758716     Source Type: Journal    
DOI: None     Document Type: Article

References (6)

1. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on development and progression of long-term complications in insulindependent diabetes mellitus. N Engl J Med. 1993;329:977-86.
2. (UKPDS) UPDSG. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet. 1998;352:837-53.
3. Dunn CJ, Plosker GL, Keating GM, et al. Insulin Glargine: An updated review of its use in the management of diabetes mellitus. Drugs. 2003;63:1743-78.
4. Rosenstock J, Bendetti MM, Haring H-U. Confirmed lower risk of hypoglycaemia with insulin glargine versus NPH insulin: a meta-analysis of 2304 patients with type 2 diabetes. In: 63rd Annual Scientific Sessions of the American Diabetes Association; 2003 Jun 13-17; New Orleans, Louisiana; 2003, Jun 13-17.
5. Ministry of Health. The New Zealand Health Strategy. Wellington: Ministry of Health; 2000. Available online. URL: http://www.moh.govt.nz/moh.nsf/0/c024d8d149d4c168cc2569b1007679ca? OpenDocument Accessed August 2005.
6. National Institute for Clinical Excellence. Guidance on the use of long-acting insulin analogues for the treatment of diabetes: insulin glargine. Technical appraisal guidance 2002; No 53.